HILLARY SOLAKIAN: Open Payments
NPI 1720630049 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,207 in 69 payments from 19 companies in 2025. Trend: 2023 $1,161 · 2024 $1,074 · 2025 $2,207
Food & beverage: $2,207
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 38 | $1,095 |
| Janssen Biotech, Inc. | 8 | $241 |
| Procept Biorobotics Corporation | 2 | $154 |
| Janssen Scientific Affairs, LLC | 1 | $146 |
| Astellas Pharma Global Development | 1 | $132 |
| UROGEN PHARMA, INC. | 2 | $50 |
| ABBVIE INC. | 2 | $47 |
| Endo USA, Inc. | 2 | $44 |
| Teleflex LLC | 1 | $40 |
| Boston Scientific Corporation | 2 | $39 |
Products named: GEMTESA, ERLEADA, AQUABEAM ROBOTIC SYSTEM, Xtandi, BOTOX, XIAFLEX, BARRIGEL, 1788.
Industry payments across CA — which companies pay providers there.
